Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OATD-01 in active pulmonary sarcoidosis
ISRCTN16728593Phase 2Completed
- Sponsor
- Molecure
- Start
- Mar 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of OATD-01 in pulmonary sarcoidosis, sponsored by Molecure. Primary endpoint: Treatment response by FDG-PET/CT at end of treatment. Started Mar 2024; status: completed.
02
Drugs
OATD-01
03
Conditions
pulmonary sarcoidosis
Beyond the preview
Go deeper on ISRCTN16728593.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN16728593.